GuruFocus Premium Membership

Serving Intelligent Investors Since 2004

Try It 100% FREE for 7 Days!

Free 7-day Trial
All Articles and Columns »

Top Insider Buy Companies: Modelez International, Starbucks Corporation, Valeant Pharmaceuticals International, Annaly Capital Management and Capine

August 27, 2013 | About:
guruek

guruek

80 followers
According to GuruFocus Insider Data, these are the largest insider buys during the past week: Modelez International Inc. (NASDAQ:MDLZ), Starbucks Corporation (NASDAQ:SBUX), Valeant Pharmaceuticals International Inc. (NYSE:VRX), Annaly Capital Management Inc. (NYSE:NLY), and Calpine Corp. (NYSE:CPN).

The overall trend of insiders is illustrated in the chart below:



Mondelez International Inc. (NASDAQ:MDLZ): Director Lewis Booth Bought 6,470 Shares

Director of Mondelez International Inc., Lewis W K Booth, bought 6,470 shares on Aug. 20 at an average price of $31.32. Mondelez International was formerly known as Kraft Foods Inc. Mondelez International Inc has a market cap of $55.77 billion; its shares were traded at around $31.32 with a P/E ratio of 29.50 and P/S ratio of 2.16. The dividend yield of Mondelez International Inc stocks is 2.17%. Mondelez International Inc had an annual average earnings growth of 0.8% over the past 10 years.

On Aug. 7, Mondelez International, Inc. reported second quarter and first half 2013 results. Net revenues were $8.6 billion, up 0.8 percent. Last week, Director Lewis W K Booth bought 6,470 shares of MDLZ stock. Operating income was $0.9 billion, down 7.7 percent, and operating income margin was 10.1 percent.

Starbucks Corporation (NASDAQ:SBUX): Director Mellody Hobson Bought 141,573 Shares

Director of Starbucks Corporation, Mellody L Hobson, bought 141,573 shares on Aug. 19 at an average price of $71.97. Starbucks Corporation was formed in 1985. The Company purchases and roasts high-quality whole bean coffees and sells them, along with fresh, rich-brewed coffees, Italian-style espresso beverages, cold blended beverages, complementary food items, a selection of teas, and beverage-related accessories and equipment, through its company-operated retail stores. Starbucks Corporation has a market cap of $54.08 billion; its shares were traded at around $71.97 with a P/E ratio of 34.36 and P/S ratio of 3.80. The dividend yield of Starbucks Corporation stocks is 1.17%. Starbucks Corporation had an annual average earnings growth of 14% over the past 10 years.

GuruFocus rated Starbucks Corporation the business predictability rank of 3-star.

On July 25, Starbucks Corporation reported financial results for its 13-week fiscal third quarter ended June 30, 2013. Total net revenues increased 13% to $3.7 billion. Global comparable store sales grew 8% driven by 7% growth in traffic; all regions accelerated over Q2. Consolidated operating income increased 25% to $615.2 million. Consolidated operating margin expanded 150 basis points to 16.4%.

Last week, Director Mellody L Hobson bought 141,573 shares of SBUX stock. CFO and CAO Troy Alstead and Chairman, President and CEO Howard D Schultz sold shares this month. Director Robert M Gates bought 3,300 shares in May. EVP, Gen. Counsel & Secretary Lucy Lee Helm, Director James G Jr Shennan, and Pres, Americas and US Clifford Burrows sold shares in May.

Valeant Pharmaceuticals International Inc. (NYSE:VRX): EVP, GC and Corporate Secretary Robert Roswell Chai-onn Bought 5,032 Shares

EVP, GC and Corp. Secretary of Valeant Pharmaceuticals International Inc. Robert Roswell Chai-onn bought 5,032 shares on Aug. 23 at an average price of $99.52. Valeant Pharmaceuticals International was formerly known as Biovail Corporation. Valeant Pharmaceuticals International Inc. has a market cap of $33.09 billion; its shares were traded at around $99.52 with a P/E ratio of 1050.50 and P/S ratio of 7.63. Valeant Pharmaceuticals International Inc. had an annual average earnings growth of 4.2% over the past 10 years.

On August 7, Valeant Pharmaceuticals International Inc. reported results for the 2nd quarter of 2013. Valeant's total revenues were $1.1 billion, up 34% compared to the second quarter of 2012, and product revenues were $1.06 billion, up 43% versus the year-ago quarter. The company reported net income of $11 million for the second quarter of 2013, or $0.03 per diluted share. On a Cash EPS basis, adjusted income was $421 million, or $1.34 per diluted share.

This month, EVP, GC and Corp. Secretary Robert Roswell Chai-onn, Senior Officer Brian Matheison Stolz, Senior Officer Laizer Kornwasser, and EVP, Company Group Chairman Laizer Kornwasser shares of VRX stock.

Annaly Capital Management, Inc. (NYSE:NLY): Director Kevin Brady Bought 9,000 Shares

Director of Annaly Capital Management, Inc., Kevin Brady, bought 9,000 shares on Aug. 20 at an average price of $11.42. Annaly Capital Management, Inc is a Maryland corporation that commenced operations on February 18, 1997. Annaly Capital Management, Inc. has a market cap of $10.82 billion; its shares were traded at around $11.42 with a P/E ratio of 3.31 and P/S ratio of 3.04. The dividend yield of Annaly Capital Management, Inc. stocks is 15.76%.

On August 7, Annaly Capital Management Inc. reported GAAP net income for the quarter ended June 30, 2013 of $1.6 billion or $1.71 per average common share as compared to GAAP net income of $870.3 million or $0.90 per average common share for the quarter ended March 31, 2013, and GAAP net loss of $91.2 million or $0.10 per average common share for the quarter ended June 30, 2012.

This month, Chairman of Board & CEO Wellington Denahan, Director Kevin Brady, Co-CIO Kristopher Robert Konrad, and Director John H Schaefer bought shares of NLY stock.

Calpine Corp (NYSE:CPN): Director David C Merritt Bought 10,000 Shares



Director of Calpine Corp David C Merritt bought 10,000 shares on Aug. 19 at an average price of $19.49. Calpine Corp is a Delaware corporation, which was established in 1984. Calpine Corp has a market cap of $8.57 billion; its shares were traded at around $19.49 with a P/E ratio of 26.18 and P/S ratio of 1.44.

On Jul. 25, Calpine Corporation reported second quarter 2013 Adjusted EBITDA of $343 million, compared to $403 million in the prior year period, and Adjusted Free Cash Flow of $38 million, or $0.08 per diluted share, compared to $87 million, or $0.19per diluted share, in the prior year period. Net Loss for the second quarter of 2013 was $70 million, or$0.16 per diluted share, compared to $329 million, or $0.69 per diluted share, in the prior year period. Net Loss, As Adjusted2, for the second quarter of 2013 was $33 million compared to Net Income, As Adjusted2, of $14 million in the prior year period.

Last week, Director David C Merritt bought 10,000 shares of CPN stock. Director Robert A Jr Mosbacher sold 8,000 shares last week. 10% Owner Advisory Corp Spo sold 16,000,000 shares in May. 10% Owner Energy Partners Master Luminus and 10% Owner Asset Partners Lp Vega sold shares in April.

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 3.0/5 (2 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK